University of Minnesota. Driven to Discover.
The next step in the deliberations is a 2-day National Academies of Science symposium in March.
Some topics: weighing risks and benefits, ethical issues, and global involvement.
The analysis is a key part of a federal review of controversial studies on H5N1 and other pathogens.
The plan includes ways to improve safety and security at US labs that conduct infectious disease research.
Recommendations include executive-level management that spells out a national plan, pulls together a policy council, and unifies the biodefense budget.
The NSABB plans to release final recommendations in spring 2016.
Imperiale MJ, Casadevall A. A new synthesis for dual use research of concern. PLoS Med 2015 Apr 14;12(4):e1001813
Rozell DJ. Assessing and managing the risks of potential pandemic pathogen research. (Letter) mBio 2015 Jul 21;6(4):e01075-15
Get CIDRAP news.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2015 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.